Skip to main content
Top
Published in: Gut Pathogens 1/2017

Open Access 01-12-2017 | Genome Report

Comparative genomic analysis of Clostridium difficile ribotype 027 strains including the newly sequenced strain NCKUH-21 isolated from a patient in Taiwan

Authors: Haruo Suzuki, Masaru Tomita, Pei-Jane Tsai, Wen-Chien Ko, Yuan-Pin Hung, I-Hsiu Huang, Jenn-Wei Chen

Published in: Gut Pathogens | Issue 1/2017

Login to get access

Abstract

Background

Clostridium difficile is a Gram-positive anaerobe and the leading cause of antibiotic-associated diarrhea worldwide. The emergence of ribotype 027 (RT027) strains is associated with increased incidence of infection and mortality. To further understand the relationship between C. difficile NCKUH-21, a RT027 strain isolated from a patient in Taiwan, and other RT027 strains, we performed whole-genome shotgun sequencing on NCKUH-21 and comparative genomic analyses.

Results

The genome size, G+C content, and gene number for the NCKUH-21 strain were determined to be similar to those for other C. difficile strains. The core genome phylogeny indicated that the five RT027 strains R20291, CD196, NCKUH-21, BI1, and 2007855 formed a clade. A pathogenicity locus, tcdR-tcdB-tcdE-orf-tcdA-tcdC, was conserved in the genome. A genomic region highly similar to the Clostridium phage \(\upvarphi\)CD38-2 was present in the NCKUH-21 strain but absent in the other RT027 strains and designated as the prophage \(\upvarphi\)NCKUH-21. The prophage \(\upvarphi\)NCKUH-21 genes were significantly higher in G+C content than the other genes in the NCKUH-21 genome, indicating that the prophage does not match the base composition of the host genome.

Conclusions

This is the first whole-genome analysis of a RT027 C. difficile strain isolated from Taiwan. Due to the high identity with \(\upvarphi\)CD38-2, the prophage identified in the NCKUH-21 genome has the potential to regulate toxin production. These results provide important information for understanding the pathogenicity of RT027 C. difficile in Taiwan.
Appendix
Available only for authorised users
Literature
1.
go back to reference Ananthakrishnan AN. Clostridium difficile infection: epidemiology, risk factors and management. Nat Rev Gastroenterol Hepatol. 2011;8(1):17–26.CrossRefPubMed Ananthakrishnan AN. Clostridium difficile infection: epidemiology, risk factors and management. Nat Rev Gastroenterol Hepatol. 2011;8(1):17–26.CrossRefPubMed
2.
go back to reference Bartlett JG, Gerding DN. Clinical recognition and diagnosis of Clostridium difficile infection. Clin Infect Dis. 2008;46(Suppl 1):S12–8.CrossRefPubMed Bartlett JG, Gerding DN. Clinical recognition and diagnosis of Clostridium difficile infection. Clin Infect Dis. 2008;46(Suppl 1):S12–8.CrossRefPubMed
4.
go back to reference O’Connor JR, Johnson S, Gerding DN. Clostridium difficile infection caused by the epidemic BI/NAP1/027 strain. Gastroenterology. 2009;136(6):1913–24.CrossRefPubMed O’Connor JR, Johnson S, Gerding DN. Clostridium difficile infection caused by the epidemic BI/NAP1/027 strain. Gastroenterology. 2009;136(6):1913–24.CrossRefPubMed
5.
go back to reference Hung YP, Cia CT, Tsai BY, Chen PC, Lin HJ, Liu HC, Lee JC, Wu YH, Tsai PJ, Ko WC. The first case of severe Clostridium difficile ribotype 027 infection in Taiwan. J Infect. 2015;70(1):98–101.CrossRefPubMed Hung YP, Cia CT, Tsai BY, Chen PC, Lin HJ, Liu HC, Lee JC, Wu YH, Tsai PJ, Ko WC. The first case of severe Clostridium difficile ribotype 027 infection in Taiwan. J Infect. 2015;70(1):98–101.CrossRefPubMed
6.
go back to reference Kurka H, Ehrenreich A, Ludwig W, Monot M, Rupnik M, Barbut F, Indra A, Dupuy B, Liebl W. Sequence similarity of Clostridium difficile strains by analysis of conserved genes and genome content is reflected by their ribotype affiliation. PLoS ONE. 2014;9(1):e86535.CrossRefPubMedPubMedCentral Kurka H, Ehrenreich A, Ludwig W, Monot M, Rupnik M, Barbut F, Indra A, Dupuy B, Liebl W. Sequence similarity of Clostridium difficile strains by analysis of conserved genes and genome content is reflected by their ribotype affiliation. PLoS ONE. 2014;9(1):e86535.CrossRefPubMedPubMedCentral
7.
go back to reference Pereira FL, Oliveira Junior CA, Silva ROS, Dorella FA, Carvalho AF, Almeida GMF, Leal CAG, Lobato FCF, Figueiredo HCP. Complete genome sequence of Peptoclostridium difficile strain Z31. Gut Pathog. 2016;8:11.CrossRefPubMedPubMedCentral Pereira FL, Oliveira Junior CA, Silva ROS, Dorella FA, Carvalho AF, Almeida GMF, Leal CAG, Lobato FCF, Figueiredo HCP. Complete genome sequence of Peptoclostridium difficile strain Z31. Gut Pathog. 2016;8:11.CrossRefPubMedPubMedCentral
8.
go back to reference Gerding DN, Johnson S, Rupnik M, Aktories K. Clostridium difficile binary toxin CDT: mechanism, epidemiology, and potential clinical importance. Gut Microbes. 2014;5(1):15–27.CrossRefPubMed Gerding DN, Johnson S, Rupnik M, Aktories K. Clostridium difficile binary toxin CDT: mechanism, epidemiology, and potential clinical importance. Gut Microbes. 2014;5(1):15–27.CrossRefPubMed
9.
go back to reference Monot M, Eckert C, Lemire A, Hamiot A, Dubois T, Tessier C, Dumoulard B, Hamel B, Petit A, Lalande V, et al. Clostridium difficile: new insights into the evolution of the pathogenicity locus. Sci Rep. 2015;5:15023.CrossRefPubMedPubMedCentral Monot M, Eckert C, Lemire A, Hamiot A, Dubois T, Tessier C, Dumoulard B, Hamel B, Petit A, Lalande V, et al. Clostridium difficile: new insights into the evolution of the pathogenicity locus. Sci Rep. 2015;5:15023.CrossRefPubMedPubMedCentral
10.
go back to reference Sekulovic O, Meessen-Pinard M, Fortier LC. Prophage-stimulated toxin production in Clostridium difficile NAP1/027 lysogens. J Bacteriol. 2011;193(11):2726–34.CrossRefPubMedPubMedCentral Sekulovic O, Meessen-Pinard M, Fortier LC. Prophage-stimulated toxin production in Clostridium difficile NAP1/027 lysogens. J Bacteriol. 2011;193(11):2726–34.CrossRefPubMedPubMedCentral
11.
go back to reference Rocha EP, Danchin A. Base composition bias might result from competition for metabolic resources. Trends Genet. 2002;18(6):291–4.CrossRefPubMed Rocha EP, Danchin A. Base composition bias might result from competition for metabolic resources. Trends Genet. 2002;18(6):291–4.CrossRefPubMed
13.
go back to reference Govind R, Fralick JA, Rolfe RD. Genomic organization and molecular characterization of Clostridium difficile bacteriophage PhiCD119. J Bacteriol. 2006;188(7):2568–77.CrossRefPubMedPubMedCentral Govind R, Fralick JA, Rolfe RD. Genomic organization and molecular characterization of Clostridium difficile bacteriophage PhiCD119. J Bacteriol. 2006;188(7):2568–77.CrossRefPubMedPubMedCentral
14.
go back to reference Lawrence JG, Ochman H. Amelioration of bacterial genomes: rates of change and exchange. J Mol Evol. 1997;44(4):383–97.CrossRefPubMed Lawrence JG, Ochman H. Amelioration of bacterial genomes: rates of change and exchange. J Mol Evol. 1997;44(4):383–97.CrossRefPubMed
15.
go back to reference Liao TL, Lin CF, Chiou CS, Shen GH, Wang J. Clostridium difficile PCR ribotype 027 emerges in Taiwan. Jpn J Infect Dis. 2015;68(4):338–40.CrossRefPubMed Liao TL, Lin CF, Chiou CS, Shen GH, Wang J. Clostridium difficile PCR ribotype 027 emerges in Taiwan. Jpn J Infect Dis. 2015;68(4):338–40.CrossRefPubMed
16.
go back to reference Lai MJ, Chiueh TS, Huang ZY, Lin JC. The first Clostridium difficile ribotype 027 strain isolated in Taiwan. J Formos Med Assoc. 2016;115(3):210–2.CrossRefPubMed Lai MJ, Chiueh TS, Huang ZY, Lin JC. The first Clostridium difficile ribotype 027 strain isolated in Taiwan. J Formos Med Assoc. 2016;115(3):210–2.CrossRefPubMed
Metadata
Title
Comparative genomic analysis of Clostridium difficile ribotype 027 strains including the newly sequenced strain NCKUH-21 isolated from a patient in Taiwan
Authors
Haruo Suzuki
Masaru Tomita
Pei-Jane Tsai
Wen-Chien Ko
Yuan-Pin Hung
I-Hsiu Huang
Jenn-Wei Chen
Publication date
01-12-2017
Publisher
BioMed Central
Published in
Gut Pathogens / Issue 1/2017
Electronic ISSN: 1757-4749
DOI
https://doi.org/10.1186/s13099-017-0219-4

Other articles of this Issue 1/2017

Gut Pathogens 1/2017 Go to the issue
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.